2012年KDIGO慢性肾脏疾病血压管理临床实践指南解读

摘要

The blood pressure management is important for delaying the progression of chronic kidney disease (CKD). Based on the evidence collected up to 2001, the National Kidney Foundation (NKF) established the “Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease” in 2004. Based on the KDOQI guideline and evidence collected up to February 2012, the “Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease”was then published in 2012. And we reviewed the essential parts of the guideline in this article.%　　合理的血压管理对延缓慢性肾脏疾病（CKD）进展具有重要意义。美国国家肾脏基金会所属“肾脏病预后质量倡议”工作组基于2001年及以前的研究证据，于2004年发布了CKD高血压及降压药临床实践指南。国际肾脏病组织“肾脏病：改善全球预后”在该指南基础上增加了2012年2月及以前的证据，颁布了2012年KDIGO慢性肾脏疾病血压管理临床实践指南。本文就该指南的精华做一介绍。